Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    NEJM Interview: Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development.

    NEJM Interview: Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development.

    FromNEJM Interviews

    Start listeningView podcast show

    NEJM Interview: Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development.

    FromNEJM Interviews

    ratings:
    Length:
    11 minutes
    Released:
    May 4, 2022
    Format:
    Podcast episode

    Description

    Kushal Kadakia is a student at Harvard Medical School with a background in delivery-system reform. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. K.T. Kadakia and H.M. Krumholz. Designing Cures 2.0 — From Corridors to Cornerstones. N Engl J Med 2022;386:1677-1679. J. Concato and J. Corrigan-Curay. Real-World Evidence — Where Are We Now? N Engl J Med 2022;386:1680-1682.
    Released:
    May 4, 2022
    Format:
    Podcast episode

    Titles in the series (100)

    The New England Journal of Medicine (NEJM) Audio interview RSS feed. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.